pharmatimes.com - News & Jobs now available on your smartphone 

PharmaTimes Magazine

UK NewsSubscribe to RSS

  • Separate pharmacy wholesaling and dispensing, MPs told

    February 02, 2012

    Pharmacy wholesaling and dispensing activities need to be legally separated, so that pharmacies who serve NHS patients directly prioritise the UK patient over and above wholesaling activities which effectively divert medicine supplies, MPs have been told

  • Competition can help the NHS, says OHE

    February 02, 2012

    Competition can help the integration of care in the NHS, and there is no evidence that it would hamper it, says a new report from the Office of Health Economics

  • NICE draft "no" for Zytiga

    February 02, 2012

    The National Institute for Health and Clinical Excellence has issued new draft guidance not recommending the use of Janssen's Zytiga (abiraterone) for prostate cancer

  • News Image

    NHS "will need reform again in five years," editors warn

    January 31, 2012

    The editors of three leading healthcare publications warn today that the NHS will need another overhaul in five years, and call for a public debate on its future to "salvage some good" from the government's "damaging" reforms.

  • News Image

    Govt urged over dementia research

    January 31, 2012

    The UK's world-renowned dementia knowledge base could be lost unless scientists have better opportunities to enter and remain in the field, the government has been warned.

  • News Image

    Govt plans new focus on children's health outcomes

    January 31, 2012

    The government has announced plans for a new focus on improving health care for children and young people.

  • News Image

    NICE final OK extends use of MabThera

    January 26, 2012

    NICE has issued final guidance recommending Roche's MabThera as an option when used in combination with a wide range of chemotherapy treatments for advanced follicular lymphoma.

  • News Image

    NICE final "no" for Avastin, Erbitux and Vectibix

    January 26, 2012

    NICE has issued final guidance not recommending the use of Roche's Avastin, Merck Serono's Erbitux or Amgen's Vectibix for the treatment of metastatic colorectal cancer that has progressed after first-line chemotherapy.

  • News Image

    Govt urged to "build on UK’s genomics lead”

    January 26, 2012

    UK patients should be able to benefit from genomic technology which can improve the NHS' understanding of the nature of disease and allow treatment to be tailored to patients' individual genetic make-up, Ministers have been told.

  • News Image

    NHS Nicholson Challenge "more important than management change," say MPs

    January 24, 2012

    NHS chief executive Sir David Nicholson's challenge to the Service to find efficiency savings totalling £20 billion by 2015 is more important than management change, says the House of Commons Health Committee.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. Next page
global audience

Website Search

Search over 18,000 news articles

Job SearchFind your next job

  • e.g. Director, Medical Sales
  • e.g. London
  • e.g. last 2 days
Elert Signup!

Popular Tags